✦ LIBER ✦

Immunogenicity of a universal HIV-1 vaccine vectored by DNA, MVA and CHADV-63 in a Phase I/IIA clinical trial

✍ Scribed by NJ Borthwick, T Ahmed, A Rose, U Ebrahimsa, A Black, E Hayton, H Yang…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P14-15 LB. The safety and immunogenicity

✍ Y Shao, T Li, H Wolf, Y Liu, Y Liu, H Wang, H Zhu, W Lv, W Lin, J Chen… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 63 KB

Safety and immunogenicity of a modified

✍ Felipe García; Juan Carlos López Bernaldo de Quirós; Carmen E. Gómez; Beatriz Pe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 533 KB

Safety and immunogenicity of recombinant

✍ Walter Jaoko; Frederick N. Nakwagala; Omu Anzala; Gloria Omosa Manyonyi; Josephi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 397 KB

Immunogenicity of CIGB-230, a therapeuti

✍ L. Alvarez-Lajonchere; N. H. Shoukry; B. Grá; Y. Amador-Cañizares; F. Helle; N. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

Lessons from IAVI-006, a Phase I clinica

✍ A. Guimarães-Walker; N. Mackie; S. McCormack; T. Hanke; C. Schmidt; J. Gilmour; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Phase I clinical trial safety of DNA- an

✍ Inese Cebere; Lucy Dorrell; Helen McShane; Alison Simmons; Sheena McCormack; Cla 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 289 KB